These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 2783473

  • 21. Modulation of 9-beta-D-arabinofuranosyladenine 5'-triphosphate and deoxyadenosine triphosphate in leukemic cells by 2'-deoxycoformycin during therapy with 9-beta-D-arabinofuranosyladenine.
    Plunkett W, Benjamin RS, Keating MJ, Freireich EJ.
    Cancer Res; 1982 May; 42(5):2092-6. PubMed ID: 6175407
    [Abstract] [Full Text] [Related]

  • 22. Inhibition of RNA synthesis by deoxyadenosine plus deoxycoformycin in resting lymphocytes.
    Matsumoto SS, Yu J, Yu AL.
    J Immunol; 1983 Dec; 131(6):2762-6. PubMed ID: 6196398
    [Abstract] [Full Text] [Related]

  • 23. S-adenosylhomocysteine catabolism and basis for acquired resistance during treatment of T-cell acute lymphoblastic leukemia with 2'-deoxycoformycin alone and in combination with 9-beta-D-arabinofuranosyladenine.
    Hershfield MS, Kredich NM, Koller CA, Mitchell BS, Kurtzberg J, Kinney TR, Falletta JM.
    Cancer Res; 1983 Jul; 43(7):3451-8. PubMed ID: 6601986
    [Abstract] [Full Text] [Related]

  • 24. Potentiation of growth-inhibitory activity of 9-beta-D-arabinofuranosyladenine by 2'-deoxycoformycin in human cultured cell lines derived from leukemias and lymphomas.
    Kuroki Y, Shimoyama M, Inaba S, Hirose M.
    Jpn J Cancer Res; 1989 May; 80(5):482-9. PubMed ID: 2502523
    [Abstract] [Full Text] [Related]

  • 25. Inhibitor of 2',5'-oligoadenylate synthetase induced in human T lymphoblastoid cell line treated with deoxyadenosine, deoxycoformycin and interferon.
    Heike T, Katamura K, Kubota M, Shinomiya K, Mikawa H.
    Biochem Biophys Res Commun; 1985 Mar 29; 127(3):1019-25. PubMed ID: 3872657
    [Abstract] [Full Text] [Related]

  • 26. Synergistic effect of 3'-deoxyadenosine N1-oxide and adenosine deaminase inhibitors on growth of Ehrlich ascites tumor cells in vivo.
    Svendsen KR, Overgaard-Hansen K, Frederiksen S.
    Cancer Chemother Pharmacol; 1988 Mar 29; 21(1):35-9. PubMed ID: 3257721
    [Abstract] [Full Text] [Related]

  • 27. 2'Deoxycoformycin and deoxyadenosine affect IL 2 production and IL 2 receptor expression of human T cells.
    Ruers TJ, Buurman WA, van der Linden CJ.
    J Immunol; 1987 Jan 01; 138(1):116-22. PubMed ID: 3097141
    [Abstract] [Full Text] [Related]

  • 28. Inhibitor of 2', 5'-oligoadenylate synthetase induced in human T lymphoblastoid cell line treated with deoxyadenosine, deoxycoformycin and interferon.
    Heike T, Katamura K, Kubota M, Shinomiya K, Mikawa H.
    Adv Exp Med Biol; 1986 Jan 01; 195 Pt B():683-7. PubMed ID: 3490130
    [No Abstract] [Full Text] [Related]

  • 29. Action of deoxycoformycin on human T cell colonies in vitro.
    Colledge NR, Krajewski AS, Smyth JF, Wyllie AH.
    Clin Exp Immunol; 1982 Oct 01; 50(1):115-22. PubMed ID: 6983406
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Effect of 2'-deoxycoformycin on erythroid, granulocytic, and T-lymphocyte colony growth.
    Aye MT, Dunne JV.
    Blood; 1981 Nov 01; 58(5):1043-6. PubMed ID: 6975136
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Inhibition of adenosine deaminase leads to enhanced antibody responses in the mouse.
    Nicholson JK, Gordon DS, McDougal JS.
    Cell Immunol; 1983 Jul 15; 79(2):320-33. PubMed ID: 6347398
    [Abstract] [Full Text] [Related]

  • 36. Deoxycoformycin-induced response in chronic lymphocytic leukaemia: deoxyadenosine toxicity in non-replicating lymphocytes.
    Kefford RF, Fox RM.
    Br J Haematol; 1982 Apr 15; 50(4):627-36. PubMed ID: 6978147
    [Abstract] [Full Text] [Related]

  • 37. Studies on the biochemical sequelae of therapy in Thy-acute lymphoblastic leukaemia with the adenosine deaminase inhibitor 2' deoxycoformycin.
    Russell NH, Prentice HG, Lee N, Piga A, Ganeshaguru K, Smyth JF, Hoffbrand AV.
    Br J Haematol; 1981 Sep 15; 49(1):1-9. PubMed ID: 6974003
    [Abstract] [Full Text] [Related]

  • 38. Action of 2'-deoxycoformycin on mitogen-induced lymphoproliferation in the neonatal period.
    Romo A, Lorente F, Salazar V.
    Allergol Immunopathol (Madr); 1988 Sep 15; 16(4):243-7. PubMed ID: 3265855
    [Abstract] [Full Text] [Related]

  • 39. Comparison of the effects on cultured L1210 leukemia cells of the ribosyl, 2'-deoxyribosyl, and xylosyl homologs of tubercidin and adenosine alone or in combination with 2'-deoxycoformycin.
    Cass CE, Selner M, Tan TH, Muhs WH, Robins MJ.
    Cancer Treat Rep; 1982 Feb 15; 66(2):317-26. PubMed ID: 6976834
    [Abstract] [Full Text] [Related]

  • 40. 2-Deoxycoformycin inhibition of intracellular phosphorylation of adenosine in Novikoff rat hepatoma cells.
    Plagemann PG, Wohlhueter RM.
    Biochem Pharmacol; 1981 Mar 01; 30(5):417-26. PubMed ID: 6971643
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.